Compare Mutual Funds

Pros
Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

INDMoney rank
-
8/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

7 Years 3 Months

13 Years 6 Months

Fund AUM

₹85 Cr

₹8365 Cr

Min Investment
  1. SIP ₹200
  2. Lumpsum ₹5000
  1. SIP ₹100
  2. Lumpsum ₹5000
Expense Ratio

1.13%

0.93%

Exit Load

1%

1%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

28

38

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(11.22%)
  2. Apollo Hospitals Enterprise Ltd(6.52%)
  3. Torrent Pharmaceuticals Ltd(6.5%)
  4. Aurobindo Pharma Ltd(5.15%)
  5. Divi's Laboratories Ltd(4.74%)
  1. Sun Pharmaceuticals Industries Ltd(13.85%)
  2. Lupin Ltd(7.95%)
  3. Dr Reddy's Laboratories Ltd(7.04%)
  4. Divi's Laboratories Ltd(6.61%)
  5. Cipla Ltd(5.47%)
No of Sectors

2

1

Top 3 Sectors
  1. Health(93.11%)
  2. Basic Materials(6.89%)

Health

(100%)

Equity %

96.12%

98.68%

Debt %

-

-

P/E

44.07

35.41

P/B

5.67

5.64

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

11.38%

9.31%

3-Month Return

11.1%

8.22%

6-Month Return

3.6%

4.98%

1-Year Return

11.96%

10.9%

3-Year Return

25.17%

25.15%

5-Year Return

12.7%

14.68%

Sharpe

0.95

1.01

Alpha

-1.16

-0.24

Beta

0.93

0.91

Standard Deviation

16.3

15.78

Information Ratio

-0.65

-0.55

Description

LIC MF Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sudhanshu Asthana

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Most Popular Comparisons